Akerna Corp. (NASDAQ: KERNW) Stock Competitors & Peer Comparison
See KERNW's competitors and their performance on the NASDAQ and across the wider stock market.
Peer Comparison Table: Medical - Healthcare Information Services Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for KERNW and its NASDAQ peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| KERNW | $0.00 | +40.00% | 162.3K | -0.00 | -$0.64 | N/A |
| GEHC | $72.75 | -0.26% | 32.9B | 15.95 | $4.56 | +0.19% |
| GEHCV | $56.00 | -4.08% | 25.5B | N/A | N/A | N/A |
| BTSG | $57.89 | -5.79% | 11.4B | 46.69 | $1.24 | N/A |
| TEM | $55.69 | +1.14% | 9.8B | -111.38 | -$0.50 | N/A |
| SGFY | $30.49 | +0.07% | 8.9B | 70.91 | $0.43 | N/A |
| HQY | $105.57 | -1.14% | 8.8B | 24.67 | $4.28 | N/A |
| TXG | $58.48 | -0.15% | 7.4B | -343.76 | -$0.17 | N/A |
| HNGE | $89.01 | -2.80% | 6.9B | 47.59 | $1.87 | N/A |
| RCM | $14.31 | N/A | 6B | -102.21 | -$0.14 | N/A |
Stock Comparison
GE HealthCare Technologies Inc. (NASDAQ: GEHC)
KERNW vs GEHC Comparison August 2026
Akerna Corp. (NASDAQ: KERNW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KERNW stands at 162.3K. In comparison, GEHC has a market cap of 32.9B. Regarding current trading prices, KERNW is priced at $0.00 on the NASDAQ, while GEHC trades at $72.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KERNW currently has a P/E ratio of -0.00, whereas GEHC's P/E ratio is 15.95. In terms of profitability, KERNW's ROE is -0.20%, compared to GEHC's ROE of +0.15%. Regarding short-term risk, KERNW is more volatile compared to GEHC. This indicates higher risk in terms of short-term price fluctuations for KERNW.Check GEHC's competition here
GE HealthCare Technologies Inc. (NASDAQ: GEHCV)
KERNW vs GEHCV Comparison August 2026
Akerna Corp. (NASDAQ: KERNW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KERNW stands at 162.3K. In comparison, GEHCV has a market cap of 25.5B. Regarding current trading prices, KERNW is priced at $0.00 on the NASDAQ, while GEHCV trades at $56.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KERNW currently has a P/E ratio of -0.00, whereas GEHCV's P/E ratio is N/A. In terms of profitability, KERNW's ROE is -0.20%, compared to GEHCV's ROE of +0.19%. Regarding short-term risk, KERNW is more volatile compared to GEHCV. This indicates higher risk in terms of short-term price fluctuations for KERNW.Check GEHCV's competition here
BrightSpring Health Services, Inc. Common Stock (NASDAQ: BTSG)
KERNW vs BTSG Comparison August 2026
Akerna Corp. (NASDAQ: KERNW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KERNW stands at 162.3K. In comparison, BTSG has a market cap of 11.4B. Regarding current trading prices, KERNW is priced at $0.00 on the NASDAQ, while BTSG trades at $57.89.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KERNW currently has a P/E ratio of -0.00, whereas BTSG's P/E ratio is 46.69. In terms of profitability, KERNW's ROE is -0.20%, compared to BTSG's ROE of +0.15%. Regarding short-term risk, KERNW is more volatile compared to BTSG. This indicates higher risk in terms of short-term price fluctuations for KERNW.Check BTSG's competition here
Tempus AI, Inc. (NASDAQ: TEM)
KERNW vs TEM Comparison August 2026
Akerna Corp. (NASDAQ: KERNW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KERNW stands at 162.3K. In comparison, TEM has a market cap of 9.8B. Regarding current trading prices, KERNW is priced at $0.00 on the NASDAQ, while TEM trades at $55.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KERNW currently has a P/E ratio of -0.00, whereas TEM's P/E ratio is -111.38. In terms of profitability, KERNW's ROE is -0.20%, compared to TEM's ROE of -0.55%. Regarding short-term risk, KERNW is more volatile compared to TEM. This indicates higher risk in terms of short-term price fluctuations for KERNW.Check TEM's competition here
Signify Health, Inc. (NYSE: SGFY)
KERNW vs SGFY Comparison August 2026
Akerna Corp. (NASDAQ: KERNW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KERNW stands at 162.3K. In comparison, SGFY has a market cap of 8.9B. Regarding current trading prices, KERNW is priced at $0.00 on the NASDAQ, while SGFY trades at $30.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KERNW currently has a P/E ratio of -0.00, whereas SGFY's P/E ratio is 70.91. In terms of profitability, KERNW's ROE is -0.20%, compared to SGFY's ROE of -0.15%. Regarding short-term risk, KERNW is more volatile compared to SGFY. This indicates higher risk in terms of short-term price fluctuations for KERNW.Check SGFY's competition here
HealthEquity, Inc. (NASDAQ: HQY)
KERNW vs HQY Comparison August 2026
Akerna Corp. (NASDAQ: KERNW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KERNW stands at 162.3K. In comparison, HQY has a market cap of 8.8B. Regarding current trading prices, KERNW is priced at $0.00 on the NASDAQ, while HQY trades at $105.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KERNW currently has a P/E ratio of -0.00, whereas HQY's P/E ratio is 24.67. In terms of profitability, KERNW's ROE is -0.20%, compared to HQY's ROE of +0.11%. Regarding short-term risk, KERNW is more volatile compared to HQY. This indicates higher risk in terms of short-term price fluctuations for KERNW.Check HQY's competition here
10x Genomics, Inc. (NASDAQ: TXG)
KERNW vs TXG Comparison August 2026
Akerna Corp. (NASDAQ: KERNW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KERNW stands at 162.3K. In comparison, TXG has a market cap of 7.4B. Regarding current trading prices, KERNW is priced at $0.00 on the NASDAQ, while TXG trades at $58.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KERNW currently has a P/E ratio of -0.00, whereas TXG's P/E ratio is -343.76. In terms of profitability, KERNW's ROE is -0.20%, compared to TXG's ROE of -0.09%. Regarding short-term risk, KERNW is more volatile compared to TXG. This indicates higher risk in terms of short-term price fluctuations for KERNW.Check TXG's competition here
Hinge Health, Inc. (NYSE: HNGE)
KERNW vs HNGE Comparison August 2026
Akerna Corp. (NASDAQ: KERNW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KERNW stands at 162.3K. In comparison, HNGE has a market cap of 6.9B. Regarding current trading prices, KERNW is priced at $0.00 on the NASDAQ, while HNGE trades at $89.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KERNW currently has a P/E ratio of -0.00, whereas HNGE's P/E ratio is 47.59. In terms of profitability, KERNW's ROE is -0.20%, compared to HNGE's ROE of +0.30%. Regarding short-term risk, KERNW is more volatile compared to HNGE. This indicates higher risk in terms of short-term price fluctuations for KERNW.Check HNGE's competition here
R1 RCM Inc. (NASDAQ: RCM)
KERNW vs RCM Comparison August 2026
Akerna Corp. (NASDAQ: KERNW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KERNW stands at 162.3K. In comparison, RCM has a market cap of 6B. Regarding current trading prices, KERNW is priced at $0.00 on the NASDAQ, while RCM trades at $14.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KERNW currently has a P/E ratio of -0.00, whereas RCM's P/E ratio is -102.21. In terms of profitability, KERNW's ROE is -0.20%, compared to RCM's ROE of +0.00%. Regarding short-term risk, KERNW is more volatile compared to RCM. This indicates higher risk in terms of short-term price fluctuations for KERNW.Check RCM's competition here
Doximity, Inc. (NYSE: DOCS)
KERNW vs DOCS Comparison August 2026
Akerna Corp. (NASDAQ: KERNW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KERNW stands at 162.3K. In comparison, DOCS has a market cap of 4.9B. Regarding current trading prices, KERNW is priced at $0.00 on the NASDAQ, while DOCS trades at $26.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KERNW currently has a P/E ratio of -0.00, whereas DOCS's P/E ratio is 17.08. In terms of profitability, KERNW's ROE is -0.20%, compared to DOCS's ROE of +0.17%. Regarding short-term risk, KERNW is more volatile compared to DOCS. This indicates higher risk in terms of short-term price fluctuations for KERNW.Check DOCS's competition here
Waystar Holding Corp. (NASDAQ: WAY)
KERNW vs WAY Comparison August 2026
Akerna Corp. (NASDAQ: KERNW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KERNW stands at 162.3K. In comparison, WAY has a market cap of 4.7B. Regarding current trading prices, KERNW is priced at $0.00 on the NASDAQ, while WAY trades at $24.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KERNW currently has a P/E ratio of -0.00, whereas WAY's P/E ratio is 16.09. In terms of profitability, KERNW's ROE is -0.20%, compared to WAY's ROE of +0.04%. Regarding short-term risk, KERNW is more volatile compared to WAY. This indicates higher risk in terms of short-term price fluctuations for KERNW.Check WAY's competition here
1Life Healthcare, Inc. (NASDAQ: ONEM)
KERNW vs ONEM Comparison August 2026
Akerna Corp. (NASDAQ: KERNW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KERNW stands at 162.3K. In comparison, ONEM has a market cap of 3.4B. Regarding current trading prices, KERNW is priced at $0.00 on the NASDAQ, while ONEM trades at $16.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KERNW currently has a P/E ratio of -0.00, whereas ONEM's P/E ratio is -7.77. In terms of profitability, KERNW's ROE is -0.20%, compared to ONEM's ROE of -0.24%. Regarding short-term risk, KERNW is more volatile compared to ONEM. This indicates higher risk in terms of short-term price fluctuations for KERNW.Check ONEM's competition here
Privia Health Group, Inc. (NASDAQ: PRVA)
KERNW vs PRVA Comparison August 2026
Akerna Corp. (NASDAQ: KERNW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KERNW stands at 162.3K. In comparison, PRVA has a market cap of 2.8B. Regarding current trading prices, KERNW is priced at $0.00 on the NASDAQ, while PRVA trades at $21.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KERNW currently has a P/E ratio of -0.00, whereas PRVA's P/E ratio is 104.67. In terms of profitability, KERNW's ROE is -0.20%, compared to PRVA's ROE of +0.00%. Regarding short-term risk, KERNW is more volatile compared to PRVA. This indicates higher risk in terms of short-term price fluctuations for KERNW.Check PRVA's competition here
Heartflow, Inc. Common Stock (NASDAQ: HTFL)
KERNW vs HTFL Comparison August 2026
Akerna Corp. (NASDAQ: KERNW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KERNW stands at 162.3K. In comparison, HTFL has a market cap of 2.5B. Regarding current trading prices, KERNW is priced at $0.00 on the NASDAQ, while HTFL trades at $29.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KERNW currently has a P/E ratio of -0.00, whereas HTFL's P/E ratio is -14.70. In terms of profitability, KERNW's ROE is -0.20%, compared to HTFL's ROE of +8.30%. Regarding short-term risk, KERNW is more volatile compared to HTFL. This indicates higher risk in terms of short-term price fluctuations for KERNW.Check HTFL's competition here
GeneDx Holdings Corp. (NASDAQ: WGS)
KERNW vs WGS Comparison August 2026
Akerna Corp. (NASDAQ: KERNW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KERNW stands at 162.3K. In comparison, WGS has a market cap of 2.4B. Regarding current trading prices, KERNW is priced at $0.00 on the NASDAQ, while WGS trades at $81.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KERNW currently has a P/E ratio of -0.00, whereas WGS's P/E ratio is 227.06. In terms of profitability, KERNW's ROE is -0.20%, compared to WGS's ROE of -0.39%. Regarding short-term risk, KERNW is more volatile compared to WGS. This indicates higher risk in terms of short-term price fluctuations for KERNW.Check WGS's competition here
Progyny, Inc. (NASDAQ: PGNY)
KERNW vs PGNY Comparison August 2026
Akerna Corp. (NASDAQ: KERNW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KERNW stands at 162.3K. In comparison, PGNY has a market cap of 2.1B. Regarding current trading prices, KERNW is priced at $0.00 on the NASDAQ, while PGNY trades at $26.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KERNW currently has a P/E ratio of -0.00, whereas PGNY's P/E ratio is 19.25. In terms of profitability, KERNW's ROE is -0.20%, compared to PGNY's ROE of +0.16%. Regarding short-term risk, KERNW is more volatile compared to PGNY. This indicates higher risk in terms of short-term price fluctuations for KERNW.Check PGNY's competition here
NextGen Healthcare, Inc. (NASDAQ: NXGN)
KERNW vs NXGN Comparison August 2026
Akerna Corp. (NASDAQ: KERNW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KERNW stands at 162.3K. In comparison, NXGN has a market cap of 1.6B. Regarding current trading prices, KERNW is priced at $0.00 on the NASDAQ, while NXGN trades at $23.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KERNW currently has a P/E ratio of -0.00, whereas NXGN's P/E ratio is -266.00. In terms of profitability, KERNW's ROE is -0.20%, compared to NXGN's ROE of -0.01%. Regarding short-term risk, KERNW is more volatile compared to NXGN. This indicates higher risk in terms of short-term price fluctuations for KERNW.Check NXGN's competition here
Omada Health (NASDAQ: OMDA)
KERNW vs OMDA Comparison August 2026
Akerna Corp. (NASDAQ: KERNW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KERNW stands at 162.3K. In comparison, OMDA has a market cap of 1.4B. Regarding current trading prices, KERNW is priced at $0.00 on the NASDAQ, while OMDA trades at $24.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KERNW currently has a P/E ratio of -0.00, whereas OMDA's P/E ratio is 343.00. In terms of profitability, KERNW's ROE is -0.20%, compared to OMDA's ROE of +0.02%. Regarding short-term risk, KERNW is more volatile compared to OMDA. This indicates higher risk in terms of short-term price fluctuations for KERNW.Check OMDA's competition here
Agiliti, Inc. (NYSE: AGTI)
KERNW vs AGTI Comparison August 2026
Akerna Corp. (NASDAQ: KERNW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KERNW stands at 162.3K. In comparison, AGTI has a market cap of 1.4B. Regarding current trading prices, KERNW is priced at $0.00 on the NASDAQ, while AGTI trades at $10.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KERNW currently has a P/E ratio of -0.00, whereas AGTI's P/E ratio is -71.79. In terms of profitability, KERNW's ROE is -0.20%, compared to AGTI's ROE of -0.02%. Regarding short-term risk, KERNW is more volatile compared to AGTI. This indicates higher risk in terms of short-term price fluctuations for KERNW.Check AGTI's competition here
GoodRx Holdings, Inc. (NASDAQ: GDRX)
KERNW vs GDRX Comparison August 2026
Akerna Corp. (NASDAQ: KERNW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KERNW stands at 162.3K. In comparison, GDRX has a market cap of 1.3B. Regarding current trading prices, KERNW is priced at $0.00 on the NASDAQ, while GDRX trades at $3.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KERNW currently has a P/E ratio of -0.00, whereas GDRX's P/E ratio is 11.88. In terms of profitability, KERNW's ROE is -0.20%, compared to GDRX's ROE of +0.03%. Regarding short-term risk, KERNW is more volatile compared to GDRX. This indicates higher risk in terms of short-term price fluctuations for KERNW.Check GDRX's competition here
Certara, Inc. (NASDAQ: CERT)
KERNW vs CERT Comparison August 2026
Akerna Corp. (NASDAQ: KERNW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KERNW stands at 162.3K. In comparison, CERT has a market cap of 1.3B. Regarding current trading prices, KERNW is priced at $0.00 on the NASDAQ, while CERT trades at $8.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KERNW currently has a P/E ratio of -0.00, whereas CERT's P/E ratio is 20.33. In terms of profitability, KERNW's ROE is -0.20%, compared to CERT's ROE of -0.07%. Regarding short-term risk, KERNW is more volatile compared to CERT. This indicates higher risk in terms of short-term price fluctuations for KERNW.Check CERT's competition here
Teladoc Health, Inc. (NYSE: TDOC)
KERNW vs TDOC Comparison August 2026
Akerna Corp. (NASDAQ: KERNW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KERNW stands at 162.3K. In comparison, TDOC has a market cap of 1.2B. Regarding current trading prices, KERNW is priced at $0.00 on the NASDAQ, while TDOC trades at $6.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KERNW currently has a P/E ratio of -0.00, whereas TDOC's P/E ratio is -7.56. In terms of profitability, KERNW's ROE is -0.20%, compared to TDOC's ROE of -0.13%. Regarding short-term risk, KERNW is more volatile compared to TDOC. This indicates higher risk in terms of short-term price fluctuations for KERNW.Check TDOC's competition here
CareCloud, Inc. (NASDAQ: CCLDO)
KERNW vs CCLDO Comparison August 2026
Akerna Corp. (NASDAQ: KERNW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KERNW stands at 162.3K. In comparison, CCLDO has a market cap of 857.3M. Regarding current trading prices, KERNW is priced at $0.00 on the NASDAQ, while CCLDO trades at $27.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KERNW currently has a P/E ratio of -0.00, whereas CCLDO's P/E ratio is N/A. In terms of profitability, KERNW's ROE is -0.20%, compared to CCLDO's ROE of +0.17%. Regarding short-term risk, KERNW is more volatile compared to CCLDO. This indicates higher risk in terms of short-term price fluctuations for KERNW.Check CCLDO's competition here
HealthStream, Inc. (NASDAQ: HSTM)
KERNW vs HSTM Comparison August 2026
Akerna Corp. (NASDAQ: KERNW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KERNW stands at 162.3K. In comparison, HSTM has a market cap of 828.5M. Regarding current trading prices, KERNW is priced at $0.00 on the NASDAQ, while HSTM trades at $28.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KERNW currently has a P/E ratio of -0.00, whereas HSTM's P/E ratio is 35.01. In terms of profitability, KERNW's ROE is -0.20%, compared to HSTM's ROE of +0.06%. Regarding short-term risk, KERNW is more volatile compared to HSTM. This indicates higher risk in terms of short-term price fluctuations for KERNW.Check HSTM's competition here
Phreesia, Inc. (NYSE: PHR)
KERNW vs PHR Comparison August 2026
Akerna Corp. (NASDAQ: KERNW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KERNW stands at 162.3K. In comparison, PHR has a market cap of 759M. Regarding current trading prices, KERNW is priced at $0.00 on the NASDAQ, while PHR trades at $12.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KERNW currently has a P/E ratio of -0.00, whereas PHR's P/E ratio is 43.86. In terms of profitability, KERNW's ROE is -0.20%, compared to PHR's ROE of +0.03%. Regarding short-term risk, KERNW is more volatile compared to PHR. This indicates higher risk in terms of short-term price fluctuations for KERNW.Check PHR's competition here
SOPHiA GENETICS S.A. (NASDAQ: SOPH)
KERNW vs SOPH Comparison August 2026
Akerna Corp. (NASDAQ: KERNW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KERNW stands at 162.3K. In comparison, SOPH has a market cap of 638.4M. Regarding current trading prices, KERNW is priced at $0.00 on the NASDAQ, while SOPH trades at $7.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KERNW currently has a P/E ratio of -0.00, whereas SOPH's P/E ratio is -6.86. In terms of profitability, KERNW's ROE is -0.20%, compared to SOPH's ROE of -1.37%. Regarding short-term risk, KERNW is more volatile compared to SOPH. This indicates higher risk in terms of short-term price fluctuations for KERNW.Check SOPH's competition here
MultiPlan Corporation (NYSE: MPLN-WT)
KERNW vs MPLN-WT Comparison August 2026
Akerna Corp. (NASDAQ: KERNW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KERNW stands at 162.3K. In comparison, MPLN-WT has a market cap of 625.2M. Regarding current trading prices, KERNW is priced at $0.00 on the NASDAQ, while MPLN-WT trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KERNW currently has a P/E ratio of -0.00, whereas MPLN-WT's P/E ratio is N/A. In terms of profitability, KERNW's ROE is -0.20%, compared to MPLN-WT's ROE of +1.40%. Regarding short-term risk, KERNW is less volatile compared to MPLN-WT. This indicates lower risk in terms of short-term price fluctuations for KERNW.Check MPLN-WT's competition here
Claritev Corporation (NYSE: CTEV)
KERNW vs CTEV Comparison August 2026
Akerna Corp. (NASDAQ: KERNW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KERNW stands at 162.3K. In comparison, CTEV has a market cap of 596M. Regarding current trading prices, KERNW is priced at $0.00 on the NASDAQ, while CTEV trades at $34.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KERNW currently has a P/E ratio of -0.00, whereas CTEV's P/E ratio is -2.06. In terms of profitability, KERNW's ROE is -0.20%, compared to CTEV's ROE of +1.40%. Regarding short-term risk, KERNW is more volatile compared to CTEV. This indicates higher risk in terms of short-term price fluctuations for KERNW.Check CTEV's competition here
Accolade, Inc. (NASDAQ: ACCD)
KERNW vs ACCD Comparison August 2026
Akerna Corp. (NASDAQ: KERNW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KERNW stands at 162.3K. In comparison, ACCD has a market cap of 575.6M. Regarding current trading prices, KERNW is priced at $0.00 on the NASDAQ, while ACCD trades at $7.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KERNW currently has a P/E ratio of -0.00, whereas ACCD's P/E ratio is -3.08. In terms of profitability, KERNW's ROE is -0.20%, compared to ACCD's ROE of -0.22%. Regarding short-term risk, KERNW is more volatile compared to ACCD. This indicates higher risk in terms of short-term price fluctuations for KERNW.Check ACCD's competition here
Sharecare, Inc. (NASDAQ: SHCR)
KERNW vs SHCR Comparison August 2026
Akerna Corp. (NASDAQ: KERNW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KERNW stands at 162.3K. In comparison, SHCR has a market cap of 531.8M. Regarding current trading prices, KERNW is priced at $0.00 on the NASDAQ, while SHCR trades at $1.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KERNW currently has a P/E ratio of -0.00, whereas SHCR's P/E ratio is -3.76. In terms of profitability, KERNW's ROE is -0.20%, compared to SHCR's ROE of -0.25%. Regarding short-term risk, KERNW is more volatile compared to SHCR. This indicates higher risk in terms of short-term price fluctuations for KERNW.Check SHCR's competition here
NRC Health (NASDAQ: NRC)
KERNW vs NRC Comparison August 2026
Akerna Corp. (NASDAQ: KERNW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KERNW stands at 162.3K. In comparison, NRC has a market cap of 481.8M. Regarding current trading prices, KERNW is priced at $0.00 on the NASDAQ, while NRC trades at $21.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KERNW currently has a P/E ratio of -0.00, whereas NRC's P/E ratio is 26.07. In terms of profitability, KERNW's ROE is -0.20%, compared to NRC's ROE of +0.48%. Regarding short-term risk, KERNW is more volatile compared to NRC. This indicates higher risk in terms of short-term price fluctuations for KERNW.Check NRC's competition here
Evolent Health, Inc. (NYSE: EVH)
KERNW vs EVH Comparison August 2026
Akerna Corp. (NASDAQ: KERNW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KERNW stands at 162.3K. In comparison, EVH has a market cap of 462.3M. Regarding current trading prices, KERNW is priced at $0.00 on the NASDAQ, while EVH trades at $4.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KERNW currently has a P/E ratio of -0.00, whereas EVH's P/E ratio is 31.62. In terms of profitability, KERNW's ROE is -0.20%, compared to EVH's ROE of -0.99%. Regarding short-term risk, KERNW is more volatile compared to EVH. This indicates higher risk in terms of short-term price fluctuations for KERNW.Check EVH's competition here
SomaLogic, Inc. (NASDAQ: SLGC)
KERNW vs SLGC Comparison August 2026
Akerna Corp. (NASDAQ: KERNW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KERNW stands at 162.3K. In comparison, SLGC has a market cap of 396.2M. Regarding current trading prices, KERNW is priced at $0.00 on the NASDAQ, while SLGC trades at $2.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KERNW currently has a P/E ratio of -0.00, whereas SLGC's P/E ratio is -3.04. In terms of profitability, KERNW's ROE is -0.20%, compared to SLGC's ROE of -0.19%. Regarding short-term risk, KERNW is more volatile compared to SLGC. This indicates higher risk in terms of short-term price fluctuations for KERNW.Check SLGC's competition here
SomaLogic, Inc. (NASDAQ: SLGCW)
KERNW vs SLGCW Comparison August 2026
Akerna Corp. (NASDAQ: KERNW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KERNW stands at 162.3K. In comparison, SLGCW has a market cap of 396.2M. Regarding current trading prices, KERNW is priced at $0.00 on the NASDAQ, while SLGCW trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KERNW currently has a P/E ratio of -0.00, whereas SLGCW's P/E ratio is -0.16. In terms of profitability, KERNW's ROE is -0.20%, compared to SLGCW's ROE of -0.19%. Regarding short-term risk, KERNW is more volatile compared to SLGCW. This indicates higher risk in terms of short-term price fluctuations for KERNW.Check SLGCW's competition here
TruBridge, Inc. (NASDAQ: TBRG)
KERNW vs TBRG Comparison August 2026
Akerna Corp. (NASDAQ: KERNW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KERNW stands at 162.3K. In comparison, TBRG has a market cap of 393.6M. Regarding current trading prices, KERNW is priced at $0.00 on the NASDAQ, while TBRG trades at $26.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KERNW currently has a P/E ratio of -0.00, whereas TBRG's P/E ratio is 9.37. In terms of profitability, KERNW's ROE is -0.20%, compared to TBRG's ROE of +0.02%. Regarding short-term risk, KERNW is more volatile compared to TBRG. This indicates higher risk in terms of short-term price fluctuations for KERNW.Check TBRG's competition here
MultiPlan Corporation (NYSE: MPLN)
KERNW vs MPLN Comparison August 2026
Akerna Corp. (NASDAQ: KERNW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KERNW stands at 162.3K. In comparison, MPLN has a market cap of 375M. Regarding current trading prices, KERNW is priced at $0.00 on the NASDAQ, while MPLN trades at $23.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KERNW currently has a P/E ratio of -0.00, whereas MPLN's P/E ratio is -0.23. In terms of profitability, KERNW's ROE is -0.20%, compared to MPLN's ROE of +1.40%. Regarding short-term risk, KERNW is more volatile compared to MPLN. This indicates higher risk in terms of short-term price fluctuations for KERNW.Check MPLN's competition here
So-Young International Inc. (NASDAQ: SY)
KERNW vs SY Comparison August 2026
Akerna Corp. (NASDAQ: KERNW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KERNW stands at 162.3K. In comparison, SY has a market cap of 290M. Regarding current trading prices, KERNW is priced at $0.00 on the NASDAQ, while SY trades at $2.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KERNW currently has a P/E ratio of -0.00, whereas SY's P/E ratio is -6.70. In terms of profitability, KERNW's ROE is -0.20%, compared to SY's ROE of -0.16%. Regarding short-term risk, KERNW is more volatile compared to SY. This indicates higher risk in terms of short-term price fluctuations for KERNW.Check SY's competition here
Tabula Rasa HealthCare, Inc. (NASDAQ: TRHC)
KERNW vs TRHC Comparison August 2026
Akerna Corp. (NASDAQ: KERNW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KERNW stands at 162.3K. In comparison, TRHC has a market cap of 284M. Regarding current trading prices, KERNW is priced at $0.00 on the NASDAQ, while TRHC trades at $10.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KERNW currently has a P/E ratio of -0.00, whereas TRHC's P/E ratio is -4.27. In terms of profitability, KERNW's ROE is -0.20%, compared to TRHC's ROE of +121.31%. Regarding short-term risk, KERNW is more volatile compared to TRHC. This indicates higher risk in terms of short-term price fluctuations for KERNW.Check TRHC's competition here
Sema4 Holdings Corp. (NASDAQ: SMFR)
KERNW vs SMFR Comparison August 2026
Akerna Corp. (NASDAQ: KERNW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KERNW stands at 162.3K. In comparison, SMFR has a market cap of 246.4M. Regarding current trading prices, KERNW is priced at $0.00 on the NASDAQ, while SMFR trades at $0.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KERNW currently has a P/E ratio of -0.00, whereas SMFR's P/E ratio is N/A. In terms of profitability, KERNW's ROE is -0.20%, compared to SMFR's ROE of -0.39%. Regarding short-term risk, KERNW is more volatile compared to SMFR. This indicates higher risk in terms of short-term price fluctuations for KERNW.Check SMFR's competition here
Spok Holdings, Inc. (NASDAQ: SPOK)
KERNW vs SPOK Comparison August 2026
Akerna Corp. (NASDAQ: KERNW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KERNW stands at 162.3K. In comparison, SPOK has a market cap of 238.9M. Regarding current trading prices, KERNW is priced at $0.00 on the NASDAQ, while SPOK trades at $11.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KERNW currently has a P/E ratio of -0.00, whereas SPOK's P/E ratio is 19.07. In terms of profitability, KERNW's ROE is -0.20%, compared to SPOK's ROE of +0.09%. Regarding short-term risk, KERNW is more volatile compared to SPOK. This indicates higher risk in terms of short-term price fluctuations for KERNW.Check SPOK's competition here
American Well Corporation (NYSE: AMWL)
KERNW vs AMWL Comparison August 2026
Akerna Corp. (NASDAQ: KERNW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KERNW stands at 162.3K. In comparison, AMWL has a market cap of 221.1M. Regarding current trading prices, KERNW is priced at $0.00 on the NASDAQ, while AMWL trades at $12.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KERNW currently has a P/E ratio of -0.00, whereas AMWL's P/E ratio is -2.94. In terms of profitability, KERNW's ROE is -0.20%, compared to AMWL's ROE of -0.33%. Regarding short-term risk, KERNW is more volatile compared to AMWL. This indicates higher risk in terms of short-term price fluctuations for KERNW.Check AMWL's competition here
Computer Programs and Systems, Inc. (NASDAQ: CPSI)
KERNW vs CPSI Comparison August 2026
Akerna Corp. (NASDAQ: KERNW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KERNW stands at 162.3K. In comparison, CPSI has a market cap of 133.7M. Regarding current trading prices, KERNW is priced at $0.00 on the NASDAQ, while CPSI trades at $9.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KERNW currently has a P/E ratio of -0.00, whereas CPSI's P/E ratio is -183.80. In terms of profitability, KERNW's ROE is -0.20%, compared to CPSI's ROE of +0.02%. Regarding short-term risk, KERNW is more volatile compared to CPSI. This indicates higher risk in terms of short-term price fluctuations for KERNW.Check CPSI's competition here
Health Catalyst, Inc. (NASDAQ: HCAT)
KERNW vs HCAT Comparison August 2026
Akerna Corp. (NASDAQ: KERNW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KERNW stands at 162.3K. In comparison, HCAT has a market cap of 130.1M. Regarding current trading prices, KERNW is priced at $0.00 on the NASDAQ, while HCAT trades at $1.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KERNW currently has a P/E ratio of -0.00, whereas HCAT's P/E ratio is 8.80. In terms of profitability, KERNW's ROE is -0.20%, compared to HCAT's ROE of -1.30%. Regarding short-term risk, KERNW is more volatile compared to HCAT. This indicates higher risk in terms of short-term price fluctuations for KERNW.Check HCAT's competition here
OptimizeRx Corp. (NASDAQ: OPRX)
KERNW vs OPRX Comparison August 2026
Akerna Corp. (NASDAQ: KERNW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KERNW stands at 162.3K. In comparison, OPRX has a market cap of 129.9M. Regarding current trading prices, KERNW is priced at $0.00 on the NASDAQ, while OPRX trades at $6.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KERNW currently has a P/E ratio of -0.00, whereas OPRX's P/E ratio is 6.35. In terms of profitability, KERNW's ROE is -0.20%, compared to OPRX's ROE of +0.05%. Regarding short-term risk, KERNW is more volatile compared to OPRX. This indicates higher risk in terms of short-term price fluctuations for KERNW.Check OPRX's competition here
Augmedix, Inc. (NASDAQ: AUGX)
KERNW vs AUGX Comparison August 2026
Akerna Corp. (NASDAQ: KERNW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KERNW stands at 162.3K. In comparison, AUGX has a market cap of 115.9M. Regarding current trading prices, KERNW is priced at $0.00 on the NASDAQ, while AUGX trades at $2.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KERNW currently has a P/E ratio of -0.00, whereas AUGX's P/E ratio is -4.99. In terms of profitability, KERNW's ROE is -0.20%, compared to AUGX's ROE of -1.55%. Regarding short-term risk, KERNW is more volatile compared to AUGX. This indicates higher risk in terms of short-term price fluctuations for KERNW.Check AUGX's competition here
CareCloud, Inc. (NASDAQ: CCLD)
KERNW vs CCLD Comparison August 2026
Akerna Corp. (NASDAQ: KERNW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KERNW stands at 162.3K. In comparison, CCLD has a market cap of 103.7M. Regarding current trading prices, KERNW is priced at $0.00 on the NASDAQ, while CCLD trades at $2.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KERNW currently has a P/E ratio of -0.00, whereas CCLD's P/E ratio is 9.38. In terms of profitability, KERNW's ROE is -0.20%, compared to CCLD's ROE of +0.17%. Regarding short-term risk, KERNW is more volatile compared to CCLD. This indicates higher risk in terms of short-term price fluctuations for KERNW.Check CCLD's competition here
SCWorx Corp. (NASDAQ: WORX)
KERNW vs WORX Comparison August 2026
Akerna Corp. (NASDAQ: KERNW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KERNW stands at 162.3K. In comparison, WORX has a market cap of 88M. Regarding current trading prices, KERNW is priced at $0.00 on the NASDAQ, while WORX trades at $5.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KERNW currently has a P/E ratio of -0.00, whereas WORX's P/E ratio is -6.40. In terms of profitability, KERNW's ROE is -0.20%, compared to WORX's ROE of -0.65%. Regarding short-term risk, KERNW is less volatile compared to WORX. This indicates lower risk in terms of short-term price fluctuations for KERNW.Check WORX's competition here
Definitive Healthcare Corp. (NASDAQ: DH)
KERNW vs DH Comparison August 2026
Akerna Corp. (NASDAQ: KERNW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KERNW stands at 162.3K. In comparison, DH has a market cap of 67.9M. Regarding current trading prices, KERNW is priced at $0.00 on the NASDAQ, while DH trades at $0.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KERNW currently has a P/E ratio of -0.00, whereas DH's P/E ratio is 2.48. In terms of profitability, KERNW's ROE is -0.20%, compared to DH's ROE of -0.75%. Regarding short-term risk, KERNW is more volatile compared to DH. This indicates higher risk in terms of short-term price fluctuations for KERNW.Check DH's competition here
Forian Inc. (NASDAQ: FORA)
KERNW vs FORA Comparison August 2026
Akerna Corp. (NASDAQ: KERNW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KERNW stands at 162.3K. In comparison, FORA has a market cap of 67.8M. Regarding current trading prices, KERNW is priced at $0.00 on the NASDAQ, while FORA trades at $2.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KERNW currently has a P/E ratio of -0.00, whereas FORA's P/E ratio is -24.11. In terms of profitability, KERNW's ROE is -0.20%, compared to FORA's ROE of -0.17%. Regarding short-term risk, KERNW is more volatile compared to FORA. This indicates higher risk in terms of short-term price fluctuations for KERNW.Check FORA's competition here
CareCloud, Inc. (NASDAQ: CCLDP)
KERNW vs CCLDP Comparison August 2026
Akerna Corp. (NASDAQ: KERNW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KERNW stands at 162.3K. In comparison, CCLDP has a market cap of 59.9M. Regarding current trading prices, KERNW is priced at $0.00 on the NASDAQ, while CCLDP trades at $19.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KERNW currently has a P/E ratio of -0.00, whereas CCLDP's P/E ratio is N/A. In terms of profitability, KERNW's ROE is -0.20%, compared to CCLDP's ROE of +0.17%. Regarding short-term risk, KERNW is more volatile compared to CCLDP. This indicates higher risk in terms of short-term price fluctuations for KERNW.Check CCLDP's competition here
OneMedNet Corporation (NASDAQ: ONMD)
KERNW vs ONMD Comparison August 2026
Akerna Corp. (NASDAQ: KERNW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KERNW stands at 162.3K. In comparison, ONMD has a market cap of 42.3M. Regarding current trading prices, KERNW is priced at $0.00 on the NASDAQ, while ONMD trades at $0.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KERNW currently has a P/E ratio of -0.00, whereas ONMD's P/E ratio is -4.95. In terms of profitability, KERNW's ROE is -0.20%, compared to ONMD's ROE of +0.90%. Regarding short-term risk, KERNW is more volatile compared to ONMD. This indicates higher risk in terms of short-term price fluctuations for KERNW.Check ONMD's competition here
Science 37 Holdings, Inc. (NASDAQ: SNCE)
KERNW vs SNCE Comparison August 2026
Akerna Corp. (NASDAQ: KERNW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KERNW stands at 162.3K. In comparison, SNCE has a market cap of 34.7M. Regarding current trading prices, KERNW is priced at $0.00 on the NASDAQ, while SNCE trades at $5.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KERNW currently has a P/E ratio of -0.00, whereas SNCE's P/E ratio is -0.27. In terms of profitability, KERNW's ROE is -0.20%, compared to SNCE's ROE of -0.47%. Regarding short-term risk, KERNW is more volatile compared to SNCE. This indicates higher risk in terms of short-term price fluctuations for KERNW.Check SNCE's competition here
Akili, Inc. (NASDAQ: AKLI)
KERNW vs AKLI Comparison August 2026
Akerna Corp. (NASDAQ: KERNW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KERNW stands at 162.3K. In comparison, AKLI has a market cap of 34.1M. Regarding current trading prices, KERNW is priced at $0.00 on the NASDAQ, while AKLI trades at $0.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KERNW currently has a P/E ratio of -0.00, whereas AKLI's P/E ratio is -0.71. In terms of profitability, KERNW's ROE is -0.20%, compared to AKLI's ROE of -0.70%. Regarding short-term risk, KERNW is more volatile compared to AKLI. This indicates higher risk in terms of short-term price fluctuations for KERNW.Check AKLI's competition here
SHL Telemedicine Ltd. (NASDAQ: SHLT)
KERNW vs SHLT Comparison August 2026
Akerna Corp. (NASDAQ: KERNW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KERNW stands at 162.3K. In comparison, SHLT has a market cap of 33.6M. Regarding current trading prices, KERNW is priced at $0.00 on the NASDAQ, while SHLT trades at $2.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KERNW currently has a P/E ratio of -0.00, whereas SHLT's P/E ratio is -3.87. In terms of profitability, KERNW's ROE is -0.20%, compared to SHLT's ROE of -0.50%. Regarding short-term risk, KERNW is more volatile compared to SHLT. This indicates higher risk in terms of short-term price fluctuations for KERNW.Check SHLT's competition here
Sharecare, Inc. (NASDAQ: SHCRW)
KERNW vs SHCRW Comparison August 2026
Akerna Corp. (NASDAQ: KERNW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KERNW stands at 162.3K. In comparison, SHCRW has a market cap of 32.5M. Regarding current trading prices, KERNW is priced at $0.00 on the NASDAQ, while SHCRW trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KERNW currently has a P/E ratio of -0.00, whereas SHCRW's P/E ratio is -0.00. In terms of profitability, KERNW's ROE is -0.20%, compared to SHCRW's ROE of -0.25%. Regarding short-term risk, KERNW is more volatile compared to SHCRW. This indicates higher risk in terms of short-term price fluctuations for KERNW.Check SHCRW's competition here
OneMedNet Corporation (NASDAQ: ONMDW)
KERNW vs ONMDW Comparison August 2026
Akerna Corp. (NASDAQ: KERNW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KERNW stands at 162.3K. In comparison, ONMDW has a market cap of 32M. Regarding current trading prices, KERNW is priced at $0.00 on the NASDAQ, while ONMDW trades at $0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KERNW currently has a P/E ratio of -0.00, whereas ONMDW's P/E ratio is N/A. In terms of profitability, KERNW's ROE is -0.20%, compared to ONMDW's ROE of +0.90%. Regarding short-term risk, KERNW is more volatile compared to ONMDW. This indicates higher risk in terms of short-term price fluctuations for KERNW.Check ONMDW's competition here
Streamline Health Solutions, Inc. (NASDAQ: STRM)
KERNW vs STRM Comparison August 2026
Akerna Corp. (NASDAQ: KERNW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KERNW stands at 162.3K. In comparison, STRM has a market cap of 23.2M. Regarding current trading prices, KERNW is priced at $0.00 on the NASDAQ, while STRM trades at $5.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KERNW currently has a P/E ratio of -0.00, whereas STRM's P/E ratio is -2.40. In terms of profitability, KERNW's ROE is -0.20%, compared to STRM's ROE of -0.65%. Regarding short-term risk, KERNW is more volatile compared to STRM. This indicates higher risk in terms of short-term price fluctuations for KERNW.Check STRM's competition here
Renalytix Plc (NASDAQ: RNLX)
KERNW vs RNLX Comparison August 2026
Akerna Corp. (NASDAQ: KERNW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KERNW stands at 162.3K. In comparison, RNLX has a market cap of 22.5M. Regarding current trading prices, KERNW is priced at $0.00 on the NASDAQ, while RNLX trades at $0.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KERNW currently has a P/E ratio of -0.00, whereas RNLX's P/E ratio is -0.33. In terms of profitability, KERNW's ROE is -0.20%, compared to RNLX's ROE of -6.31%. Regarding short-term risk, KERNW is more volatile compared to RNLX. This indicates higher risk in terms of short-term price fluctuations for KERNW.Check RNLX's competition here
MSP Recovery, Inc. (NASDAQ: LIFW)
KERNW vs LIFW Comparison August 2026
Akerna Corp. (NASDAQ: KERNW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KERNW stands at 162.3K. In comparison, LIFW has a market cap of 22.4M. Regarding current trading prices, KERNW is priced at $0.00 on the NASDAQ, while LIFW trades at $3.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KERNW currently has a P/E ratio of -0.00, whereas LIFW's P/E ratio is -0.02. In terms of profitability, KERNW's ROE is -0.20%, compared to LIFW's ROE of +1.56%. Regarding short-term risk, KERNW is more volatile compared to LIFW. This indicates higher risk in terms of short-term price fluctuations for KERNW.Check LIFW's competition here
Scienture Holdings, Inc. (NASDAQ: SCNX)
KERNW vs SCNX Comparison August 2026
Akerna Corp. (NASDAQ: KERNW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KERNW stands at 162.3K. In comparison, SCNX has a market cap of 16.6M. Regarding current trading prices, KERNW is priced at $0.00 on the NASDAQ, while SCNX trades at $0.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KERNW currently has a P/E ratio of -0.00, whereas SCNX's P/E ratio is -0.16. In terms of profitability, KERNW's ROE is -0.20%, compared to SCNX's ROE of -0.00%. Regarding short-term risk, KERNW is more volatile compared to SCNX. This indicates higher risk in terms of short-term price fluctuations for KERNW.Check SCNX's competition here
Babylon Holdings Limited (NYSE: BBLN)
KERNW vs BBLN Comparison August 2026
Akerna Corp. (NASDAQ: KERNW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KERNW stands at 162.3K. In comparison, BBLN has a market cap of 14.1M. Regarding current trading prices, KERNW is priced at $0.00 on the NASDAQ, while BBLN trades at $0.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KERNW currently has a P/E ratio of -0.00, whereas BBLN's P/E ratio is -0.04. In terms of profitability, KERNW's ROE is -0.20%, compared to BBLN's ROE of +4.89%. Regarding short-term risk, KERNW is more volatile compared to BBLN. This indicates higher risk in terms of short-term price fluctuations for KERNW.Check BBLN's competition here
HeartBeam, Inc. (NASDAQ: BEATW)
KERNW vs BEATW Comparison August 2026
Akerna Corp. (NASDAQ: KERNW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KERNW stands at 162.3K. In comparison, BEATW has a market cap of 11.7M. Regarding current trading prices, KERNW is priced at $0.00 on the NASDAQ, while BEATW trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KERNW currently has a P/E ratio of -0.00, whereas BEATW's P/E ratio is -0.03. In terms of profitability, KERNW's ROE is -0.20%, compared to BEATW's ROE of -10.34%. Regarding short-term risk, KERNW is more volatile compared to BEATW. This indicates higher risk in terms of short-term price fluctuations for KERNW.Check BEATW's competition here
Bullfrog AI Holdings, Inc. Common Stock (NASDAQ: BFRG)
KERNW vs BFRG Comparison August 2026
Akerna Corp. (NASDAQ: KERNW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KERNW stands at 162.3K. In comparison, BFRG has a market cap of 10.8M. Regarding current trading prices, KERNW is priced at $0.00 on the NASDAQ, while BFRG trades at $0.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KERNW currently has a P/E ratio of -0.00, whereas BFRG's P/E ratio is -1.08. In terms of profitability, KERNW's ROE is -0.20%, compared to BFRG's ROE of -2.18%. Regarding short-term risk, KERNW is more volatile compared to BFRG. This indicates higher risk in terms of short-term price fluctuations for KERNW.Check BFRG's competition here
ETAO International Co., Ltd. (NASDAQ: ETAO)
KERNW vs ETAO Comparison August 2026
Akerna Corp. (NASDAQ: KERNW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KERNW stands at 162.3K. In comparison, ETAO has a market cap of 9.8M. Regarding current trading prices, KERNW is priced at $0.00 on the NASDAQ, while ETAO trades at $1.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KERNW currently has a P/E ratio of -0.00, whereas ETAO's P/E ratio is -0.01. In terms of profitability, KERNW's ROE is -0.20%, compared to ETAO's ROE of -13.69%. Regarding short-term risk, KERNW is more volatile compared to ETAO. This indicates higher risk in terms of short-term price fluctuations for KERNW.Check ETAO's competition here
Mangoceuticals, Inc. (NASDAQ: MGRX)
KERNW vs MGRX Comparison August 2026
Akerna Corp. (NASDAQ: KERNW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KERNW stands at 162.3K. In comparison, MGRX has a market cap of 9.3M. Regarding current trading prices, KERNW is priced at $0.00 on the NASDAQ, while MGRX trades at $0.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KERNW currently has a P/E ratio of -0.00, whereas MGRX's P/E ratio is -0.40. In terms of profitability, KERNW's ROE is -0.20%, compared to MGRX's ROE of -1.21%. Regarding short-term risk, KERNW is more volatile compared to MGRX. This indicates higher risk in terms of short-term price fluctuations for KERNW.Check MGRX's competition here
UpHealth, Inc. (NYSE: UPH)
KERNW vs UPH Comparison August 2026
Akerna Corp. (NASDAQ: KERNW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KERNW stands at 162.3K. In comparison, UPH has a market cap of 5.3M. Regarding current trading prices, KERNW is priced at $0.00 on the NASDAQ, while UPH trades at $0.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KERNW currently has a P/E ratio of -0.00, whereas UPH's P/E ratio is -0.07. In terms of profitability, KERNW's ROE is -0.20%, compared to UPH's ROE of -1.05%. Regarding short-term risk, KERNW is more volatile compared to UPH. This indicates higher risk in terms of short-term price fluctuations for KERNW.Check UPH's competition here
UpHealth, Inc. (NYSE: UPH-WT)
KERNW vs UPH-WT Comparison August 2026
Akerna Corp. (NASDAQ: KERNW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KERNW stands at 162.3K. In comparison, UPH-WT has a market cap of 5.3M. Regarding current trading prices, KERNW is priced at $0.00 on the NASDAQ, while UPH-WT trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KERNW currently has a P/E ratio of -0.00, whereas UPH-WT's P/E ratio is N/A. In terms of profitability, KERNW's ROE is -0.20%, compared to UPH-WT's ROE of -1.05%. Regarding short-term risk, KERNW is more volatile compared to UPH-WT. This indicates higher risk in terms of short-term price fluctuations for KERNW.Check UPH-WT's competition here
Pear Therapeutics, Inc. (NASDAQ: PEAR)
KERNW vs PEAR Comparison August 2026
Akerna Corp. (NASDAQ: KERNW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KERNW stands at 162.3K. In comparison, PEAR has a market cap of 4.1M. Regarding current trading prices, KERNW is priced at $0.00 on the NASDAQ, while PEAR trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KERNW currently has a P/E ratio of -0.00, whereas PEAR's P/E ratio is -0.08. In terms of profitability, KERNW's ROE is -0.20%, compared to PEAR's ROE of -0.39%. Regarding short-term risk, KERNW is more volatile compared to PEAR. This indicates higher risk in terms of short-term price fluctuations for KERNW.Check PEAR's competition here
Pear Therapeutics, Inc. (NASDAQ: PEARW)
KERNW vs PEARW Comparison August 2026
Akerna Corp. (NASDAQ: KERNW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KERNW stands at 162.3K. In comparison, PEARW has a market cap of 4.1M. Regarding current trading prices, KERNW is priced at $0.00 on the NASDAQ, while PEARW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KERNW currently has a P/E ratio of -0.00, whereas PEARW's P/E ratio is -0.00. In terms of profitability, KERNW's ROE is -0.20%, compared to PEARW's ROE of -0.39%. Regarding short-term risk, KERNW is more volatile compared to PEARW. This indicates higher risk in terms of short-term price fluctuations for KERNW.Check PEARW's competition here
Ontrak, Inc. (NASDAQ: OTRK)
KERNW vs OTRK Comparison August 2026
Akerna Corp. (NASDAQ: KERNW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KERNW stands at 162.3K. In comparison, OTRK has a market cap of 2.3M. Regarding current trading prices, KERNW is priced at $0.00 on the NASDAQ, while OTRK trades at $0.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KERNW currently has a P/E ratio of -0.00, whereas OTRK's P/E ratio is -0.02. In terms of profitability, KERNW's ROE is -0.20%, compared to OTRK's ROE of -2.11%. Regarding short-term risk, KERNW is more volatile compared to OTRK. This indicates higher risk in terms of short-term price fluctuations for KERNW.Check OTRK's competition here
CareMax, Inc. (NASDAQ: CMAX)
KERNW vs CMAX Comparison August 2026
Akerna Corp. (NASDAQ: KERNW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KERNW stands at 162.3K. In comparison, CMAX has a market cap of 1.6M. Regarding current trading prices, KERNW is priced at $0.00 on the NASDAQ, while CMAX trades at $0.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KERNW currently has a P/E ratio of -0.00, whereas CMAX's P/E ratio is -0.00. In terms of profitability, KERNW's ROE is -0.20%, compared to CMAX's ROE of -2.01%. Regarding short-term risk, KERNW is more volatile compared to CMAX. This indicates higher risk in terms of short-term price fluctuations for KERNW.Check CMAX's competition here
Healthcare Triangle, Inc. (NASDAQ: HCTI)
KERNW vs HCTI Comparison August 2026
Akerna Corp. (NASDAQ: KERNW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KERNW stands at 162.3K. In comparison, HCTI has a market cap of 1.5M. Regarding current trading prices, KERNW is priced at $0.00 on the NASDAQ, while HCTI trades at $1.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KERNW currently has a P/E ratio of -0.00, whereas HCTI's P/E ratio is -0.16. In terms of profitability, KERNW's ROE is -0.20%, compared to HCTI's ROE of -0.68%. Regarding short-term risk, KERNW is more volatile compared to HCTI. This indicates higher risk in terms of short-term price fluctuations for KERNW.Check HCTI's competition here
VSee Health, Inc. (NASDAQ: VSEEW)
KERNW vs VSEEW Comparison August 2026
Akerna Corp. (NASDAQ: KERNW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KERNW stands at 162.3K. In comparison, VSEEW has a market cap of 1.4M. Regarding current trading prices, KERNW is priced at $0.00 on the NASDAQ, while VSEEW trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KERNW currently has a P/E ratio of -0.00, whereas VSEEW's P/E ratio is -0.04. In terms of profitability, KERNW's ROE is -0.20%, compared to VSEEW's ROE of -115.71%. Regarding short-term risk, KERNW is less volatile compared to VSEEW. This indicates lower risk in terms of short-term price fluctuations for KERNW.Check VSEEW's competition here
MSP Recovery, Inc. (NASDAQ: LIFWZ)
KERNW vs LIFWZ Comparison August 2026
Akerna Corp. (NASDAQ: KERNW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KERNW stands at 162.3K. In comparison, LIFWZ has a market cap of 1.3M. Regarding current trading prices, KERNW is priced at $0.00 on the NASDAQ, while LIFWZ trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KERNW currently has a P/E ratio of -0.00, whereas LIFWZ's P/E ratio is N/A. In terms of profitability, KERNW's ROE is -0.20%, compared to LIFWZ's ROE of +1.56%. Regarding short-term risk, KERNW is more volatile compared to LIFWZ. This indicates higher risk in terms of short-term price fluctuations for KERNW.Check LIFWZ's competition here
Aclarion, Inc. (NASDAQ: ACON)
KERNW vs ACON Comparison August 2026
Akerna Corp. (NASDAQ: KERNW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KERNW stands at 162.3K. In comparison, ACON has a market cap of 1.2M. Regarding current trading prices, KERNW is priced at $0.00 on the NASDAQ, while ACON trades at $2.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KERNW currently has a P/E ratio of -0.00, whereas ACON's P/E ratio is -0.25. In terms of profitability, KERNW's ROE is -0.20%, compared to ACON's ROE of -0.59%. Regarding short-term risk, KERNW is more volatile compared to ACON. This indicates higher risk in terms of short-term price fluctuations for KERNW.Check ACON's competition here
EUDA Health Holdings Limited (NASDAQ: EUDAW)
KERNW vs EUDAW Comparison August 2026
Akerna Corp. (NASDAQ: KERNW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KERNW stands at 162.3K. In comparison, EUDAW has a market cap of 862K. Regarding current trading prices, KERNW is priced at $0.00 on the NASDAQ, while EUDAW trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KERNW currently has a P/E ratio of -0.00, whereas EUDAW's P/E ratio is 0.03. In terms of profitability, KERNW's ROE is -0.20%, compared to EUDAW's ROE of +1.20%. Regarding short-term risk, KERNW is more volatile compared to EUDAW. This indicates higher risk in terms of short-term price fluctuations for KERNW.Check EUDAW's competition here
VSee Health, Inc. (NASDAQ: VSEE)
KERNW vs VSEE Comparison August 2026
Akerna Corp. (NASDAQ: KERNW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KERNW stands at 162.3K. In comparison, VSEE has a market cap of 816.5K. Regarding current trading prices, KERNW is priced at $0.00 on the NASDAQ, while VSEE trades at $0.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KERNW currently has a P/E ratio of -0.00, whereas VSEE's P/E ratio is -0.10. In terms of profitability, KERNW's ROE is -0.20%, compared to VSEE's ROE of -115.71%. Regarding short-term risk, KERNW is more volatile compared to VSEE. This indicates higher risk in terms of short-term price fluctuations for KERNW.Check VSEE's competition here
MSP Recovery, Inc. (NASDAQ: MSPRZ)
KERNW vs MSPRZ Comparison August 2026
Akerna Corp. (NASDAQ: KERNW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KERNW stands at 162.3K. In comparison, MSPRZ has a market cap of 550.4K. Regarding current trading prices, KERNW is priced at $0.00 on the NASDAQ, while MSPRZ trades at $0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KERNW currently has a P/E ratio of -0.00, whereas MSPRZ's P/E ratio is N/A. In terms of profitability, KERNW's ROE is -0.20%, compared to MSPRZ's ROE of +1.56%. Regarding short-term risk, KERNW is less volatile compared to MSPRZ. This indicates lower risk in terms of short-term price fluctuations for KERNW.Check MSPRZ's competition here
Akerna Corp. (NASDAQ: KERN)
KERNW vs KERN Comparison August 2026
Akerna Corp. (NASDAQ: KERNW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KERNW stands at 162.3K. In comparison, KERN has a market cap of 162.3K. Regarding current trading prices, KERNW is priced at $0.00 on the NASDAQ, while KERN trades at $0.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KERNW currently has a P/E ratio of -0.00, whereas KERN's P/E ratio is -0.01. In terms of profitability, KERNW's ROE is -0.20%, compared to KERN's ROE of -0.20%. Regarding short-term risk, KERNW is more volatile compared to KERN. This indicates higher risk in terms of short-term price fluctuations for KERNW.Check KERN's competition here
MSP Recovery, Inc. (NASDAQ: LIFWW)
KERNW vs LIFWW Comparison August 2026
Akerna Corp. (NASDAQ: KERNW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KERNW stands at 162.3K. In comparison, LIFWW has a market cap of 60.1K. Regarding current trading prices, KERNW is priced at $0.00 on the NASDAQ, while LIFWW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KERNW currently has a P/E ratio of -0.00, whereas LIFWW's P/E ratio is N/A. In terms of profitability, KERNW's ROE is -0.20%, compared to LIFWW's ROE of +1.56%. Regarding short-term risk, KERNW is more volatile compared to LIFWW. This indicates higher risk in terms of short-term price fluctuations for KERNW.Check LIFWW's competition here
Zhongchao Inc. (NASDAQ: ZCMD)
KERNW vs ZCMD Comparison August 2026
Akerna Corp. (NASDAQ: KERNW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KERNW stands at 162.3K. In comparison, ZCMD has a market cap of 37.5K. Regarding current trading prices, KERNW is priced at $0.00 on the NASDAQ, while ZCMD trades at $1.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KERNW currently has a P/E ratio of -0.00, whereas ZCMD's P/E ratio is -0.04. In terms of profitability, KERNW's ROE is -0.20%, compared to ZCMD's ROE of -0.32%. Regarding short-term risk, KERNW is more volatile compared to ZCMD. This indicates higher risk in terms of short-term price fluctuations for KERNW.Check ZCMD's competition here
CareMax, Inc. (NASDAQ: CMAXW)
KERNW vs CMAXW Comparison August 2026
Akerna Corp. (NASDAQ: KERNW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KERNW stands at 162.3K. In comparison, CMAXW has a market cap of 36.4K. Regarding current trading prices, KERNW is priced at $0.00 on the NASDAQ, while CMAXW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KERNW currently has a P/E ratio of -0.00, whereas CMAXW's P/E ratio is N/A. In terms of profitability, KERNW's ROE is -0.20%, compared to CMAXW's ROE of -2.01%. Regarding short-term risk, KERNW is more volatile compared to CMAXW. This indicates higher risk in terms of short-term price fluctuations for KERNW.Check CMAXW's competition here
Aclarion, Inc. (NASDAQ: ACONW)
KERNW vs ACONW Comparison August 2026
Akerna Corp. (NASDAQ: KERNW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KERNW stands at 162.3K. In comparison, ACONW has a market cap of 13.1K. Regarding current trading prices, KERNW is priced at $0.00 on the NASDAQ, while ACONW trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KERNW currently has a P/E ratio of -0.00, whereas ACONW's P/E ratio is N/A. In terms of profitability, KERNW's ROE is -0.20%, compared to ACONW's ROE of -0.59%. Regarding short-term risk, KERNW is more volatile compared to ACONW. This indicates higher risk in terms of short-term price fluctuations for KERNW.Check ACONW's competition here
GeneDx Holdings Corp. (NASDAQ: WGSWW)
KERNW vs WGSWW Comparison August 2026
Akerna Corp. (NASDAQ: KERNW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KERNW stands at 162.3K. In comparison, WGSWW has a market cap of 5.8K. Regarding current trading prices, KERNW is priced at $0.00 on the NASDAQ, while WGSWW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KERNW currently has a P/E ratio of -0.00, whereas WGSWW's P/E ratio is -0.00. In terms of profitability, KERNW's ROE is -0.20%, compared to WGSWW's ROE of -0.39%. Regarding short-term risk, KERNW is more volatile compared to WGSWW. This indicates higher risk in terms of short-term price fluctuations for KERNW.Check WGSWW's competition here
Change Healthcare Inc. (NASDAQ: CHNGU)
KERNW vs CHNGU Comparison August 2026
Akerna Corp. (NASDAQ: KERNW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KERNW stands at 162.3K. In comparison, CHNGU has a market cap of 0. Regarding current trading prices, KERNW is priced at $0.00 on the NASDAQ, while CHNGU trades at $73.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KERNW currently has a P/E ratio of -0.00, whereas CHNGU's P/E ratio is N/A. In terms of profitability, KERNW's ROE is -0.20%, compared to CHNGU's ROE of -0.05%. Regarding short-term risk, KERNW is more volatile compared to CHNGU. This indicates higher risk in terms of short-term price fluctuations for KERNW.Check CHNGU's competition here
Convey Health Solutions Holdings, Inc. (NYSE: CNVY)
KERNW vs CNVY Comparison August 2026
Akerna Corp. (NASDAQ: KERNW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KERNW stands at 162.3K. In comparison, CNVY has a market cap of 0. Regarding current trading prices, KERNW is priced at $0.00 on the NASDAQ, while CNVY trades at $10.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KERNW currently has a P/E ratio of -0.00, whereas CNVY's P/E ratio is -71.50. In terms of profitability, KERNW's ROE is -0.20%, compared to CNVY's ROE of -0.02%. Regarding short-term risk, KERNW is more volatile compared to CNVY. This indicates higher risk in terms of short-term price fluctuations for KERNW.Check CNVY's competition here
Cerner Corporation (NASDAQ: CERN)
KERNW vs CERN Comparison August 2026
Akerna Corp. (NASDAQ: KERNW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KERNW stands at 162.3K. In comparison, CERN has a market cap of 0. Regarding current trading prices, KERNW is priced at $0.00 on the NASDAQ, while CERN trades at $94.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KERNW currently has a P/E ratio of -0.00, whereas CERN's P/E ratio is 55.84. In terms of profitability, KERNW's ROE is -0.20%, compared to CERN's ROE of +0.14%. Regarding short-term risk, KERNW is more volatile compared to CERN. This indicates higher risk in terms of short-term price fluctuations for KERNW.Check CERN's competition here
Alkuri Global Acquisition Corp. (NASDAQ: KURIU)
KERNW vs KURIU Comparison August 2026
Akerna Corp. (NASDAQ: KERNW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KERNW stands at 162.3K. In comparison, KURIU has a market cap of 0. Regarding current trading prices, KERNW is priced at $0.00 on the NASDAQ, while KURIU trades at $9.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KERNW currently has a P/E ratio of -0.00, whereas KURIU's P/E ratio is N/A. In terms of profitability, KERNW's ROE is -0.20%, compared to KURIU's ROE of +1.06%. Regarding short-term risk, KERNW is more volatile compared to KURIU. This indicates higher risk in terms of short-term price fluctuations for KERNW.Check KURIU's competition here
NantHealth, Inc. (NASDAQ: NH)
KERNW vs NH Comparison August 2026
Akerna Corp. (NASDAQ: KERNW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KERNW stands at 162.3K. In comparison, NH has a market cap of 0. Regarding current trading prices, KERNW is priced at $0.00 on the NASDAQ, while NH trades at $1.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KERNW currently has a P/E ratio of -0.00, whereas NH's P/E ratio is -0.12. In terms of profitability, KERNW's ROE is -0.20%, compared to NH's ROE of +0.35%. Regarding short-term risk, KERNW is more volatile compared to NH. This indicates higher risk in terms of short-term price fluctuations for KERNW.Check NH's competition here
CareCloud, Inc. (NASDAQ: MTBC)
KERNW vs MTBC Comparison August 2026
Akerna Corp. (NASDAQ: KERNW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KERNW stands at 162.3K. In comparison, MTBC has a market cap of 0. Regarding current trading prices, KERNW is priced at $0.00 on the NASDAQ, while MTBC trades at $3.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KERNW currently has a P/E ratio of -0.00, whereas MTBC's P/E ratio is N/A. In terms of profitability, KERNW's ROE is -0.20%, compared to MTBC's ROE of +0.19%. Regarding short-term risk, KERNW is more volatile compared to MTBC. This indicates higher risk in terms of short-term price fluctuations for KERNW.Check MTBC's competition here
Sema4 Holdings Corp. (NASDAQ: SMFRW)
KERNW vs SMFRW Comparison August 2026
Akerna Corp. (NASDAQ: KERNW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KERNW stands at 162.3K. In comparison, SMFRW has a market cap of 0. Regarding current trading prices, KERNW is priced at $0.00 on the NASDAQ, while SMFRW trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KERNW currently has a P/E ratio of -0.00, whereas SMFRW's P/E ratio is N/A. In terms of profitability, KERNW's ROE is -0.20%, compared to SMFRW's ROE of -0.39%. Regarding short-term risk, KERNW is more volatile compared to SMFRW. This indicates higher risk in terms of short-term price fluctuations for KERNW.Check SMFRW's competition here
Change Healthcare Inc. (NASDAQ: CHNG)
KERNW vs CHNG Comparison August 2026
Akerna Corp. (NASDAQ: KERNW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KERNW stands at 162.3K. In comparison, CHNG has a market cap of 0. Regarding current trading prices, KERNW is priced at $0.00 on the NASDAQ, while CHNG trades at $27.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KERNW currently has a P/E ratio of -0.00, whereas CHNG's P/E ratio is -152.72. In terms of profitability, KERNW's ROE is -0.20%, compared to CHNG's ROE of -0.05%. Regarding short-term risk, KERNW is more volatile compared to CHNG. This indicates higher risk in terms of short-term price fluctuations for KERNW.Check CHNG's competition here
MSP Recovery, Inc. (NASDAQ: MSPRV)
KERNW vs MSPRV Comparison August 2026
Akerna Corp. (NASDAQ: KERNW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KERNW stands at 162.3K. In comparison, MSPRV has a market cap of 0. Regarding current trading prices, KERNW is priced at $0.00 on the NASDAQ, while MSPRV trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KERNW currently has a P/E ratio of -0.00, whereas MSPRV's P/E ratio is N/A. In terms of profitability, KERNW's ROE is -0.20%, compared to MSPRV's ROE of N/A. Regarding short-term risk, KERNW is more volatile compared to MSPRV. This indicates higher risk in terms of short-term price fluctuations for KERNW.Check MSPRV's competition here
Nava Health MD, LLC (NASDAQ: NAVA)
KERNW vs NAVA Comparison August 2026
Akerna Corp. (NASDAQ: KERNW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KERNW stands at 162.3K. In comparison, NAVA has a market cap of 0. Regarding current trading prices, KERNW is priced at $0.00 on the NASDAQ, while NAVA trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KERNW currently has a P/E ratio of -0.00, whereas NAVA's P/E ratio is N/A. In terms of profitability, KERNW's ROE is -0.20%, compared to NAVA's ROE of +0.15%. Regarding short-term risk, KERNW is not fully comparable compared to NAVA. This indicates unavailable risk data in terms of short-term price fluctuations for KERNW.Check NAVA's competition here
IMS Health Holdings, Inc. (NYSE: IMS)
KERNW vs IMS Comparison August 2026
Akerna Corp. (NASDAQ: KERNW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KERNW stands at 162.3K. In comparison, IMS has a market cap of 0. Regarding current trading prices, KERNW is priced at $0.00 on the NASDAQ, while IMS trades at $31.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KERNW currently has a P/E ratio of -0.00, whereas IMS's P/E ratio is N/A. In terms of profitability, KERNW's ROE is -0.20%, compared to IMS's ROE of +0.27%. Regarding short-term risk, KERNW is more volatile compared to IMS. This indicates higher risk in terms of short-term price fluctuations for KERNW.Check IMS's competition here
CareCloud, Inc. (NASDAQ: MTBCP)
KERNW vs MTBCP Comparison August 2026
Akerna Corp. (NASDAQ: KERNW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KERNW stands at 162.3K. In comparison, MTBCP has a market cap of 0. Regarding current trading prices, KERNW is priced at $0.00 on the NASDAQ, while MTBCP trades at $26.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KERNW currently has a P/E ratio of -0.00, whereas MTBCP's P/E ratio is N/A. In terms of profitability, KERNW's ROE is -0.20%, compared to MTBCP's ROE of +0.17%. Regarding short-term risk, KERNW is more volatile compared to MTBCP. This indicates higher risk in terms of short-term price fluctuations for KERNW.Check MTBCP's competition here
Castlight Health, Inc. (NYSE: CSLT)
KERNW vs CSLT Comparison August 2026
Akerna Corp. (NASDAQ: KERNW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KERNW stands at 162.3K. In comparison, CSLT has a market cap of 0. Regarding current trading prices, KERNW is priced at $0.00 on the NASDAQ, while CSLT trades at $2.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KERNW currently has a P/E ratio of -0.00, whereas CSLT's P/E ratio is -37.27. In terms of profitability, KERNW's ROE is -0.20%, compared to CSLT's ROE of -0.42%. Regarding short-term risk, KERNW is more volatile compared to CSLT. This indicates higher risk in terms of short-term price fluctuations for KERNW.Check CSLT's competition here
Affymetrix, Inc. (NASDAQ: AFFX)
KERNW vs AFFX Comparison August 2026
Akerna Corp. (NASDAQ: KERNW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KERNW stands at 162.3K. In comparison, AFFX has a market cap of 0. Regarding current trading prices, KERNW is priced at $0.00 on the NASDAQ, while AFFX trades at $14.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KERNW currently has a P/E ratio of -0.00, whereas AFFX's P/E ratio is N/A. In terms of profitability, KERNW's ROE is -0.20%, compared to AFFX's ROE of +0.03%. Regarding short-term risk, KERNW is more volatile compared to AFFX. This indicates higher risk in terms of short-term price fluctuations for KERNW.Check AFFX's competition here
CareCloud, Inc. (NASDAQ: MTBCO)
KERNW vs MTBCO Comparison August 2026
Akerna Corp. (NASDAQ: KERNW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KERNW stands at 162.3K. In comparison, MTBCO has a market cap of 0. Regarding current trading prices, KERNW is priced at $0.00 on the NASDAQ, while MTBCO trades at $25.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KERNW currently has a P/E ratio of -0.00, whereas MTBCO's P/E ratio is N/A. In terms of profitability, KERNW's ROE is -0.20%, compared to MTBCO's ROE of +0.17%. Regarding short-term risk, KERNW is more volatile compared to MTBCO. This indicates higher risk in terms of short-term price fluctuations for KERNW.Check MTBCO's competition here